Tag Archives: browser

Toughest breast cancer may have met its match: Protein inhibitor makes cell susceptible to chemotherapy — ScienceDaily

A report of their findings was published online in the journal Proceedings of the National Academy of Sciences on Dec. 1. Triple-negative breast cancers account for about 20 percent of all breast cancers in the United States, and 30 percent of all breast cancers in African-American women. …

Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds

The study suggests that attacking those subsets with targeted drugs may degrade the disease’s ability to spread throughout the bone marrow of affected patients, the authors say. The discovery was made by developing a mouse model of the disease that enabled researchers to track which of 15 genetic groups — or subclones — of myeloma cells spread beyond their initial site in the animals’ hind legs. By labeling the different subgroups with fluorescent dyes, researchers determined that just one of the subclones was responsible for the disease metastasis. They then compared the pattern of gene abnormalities in the initial myeloma tissue and the metastatic tumors. …

Disorder in gene-control system is a defining characteristic of cancer, study finds

The researchers also showed that derangement in the methylation process has a direct bearing on the effectiveness of cancer therapy. In patients with chronic lymphocytic leukemia (CLL), they found that treatment produced shorter remissions if the tumor tissue showed signs of highly disorganized methylation. The findings demonstrate that such disorganization can actually benefit tumors and render them less vulnerable to anti-cancer drugs. …

Injectable 3-D vaccines could fight cancer, infectious diseases

“We can create 3D structures using minimally-invasive delivery to enrich and activate a host’s immune cells to target and attack harmful cells in vivo,” said the study’s senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty member and the Robert P. Pinkas Professor of Bioengineering at Harvard SEAS. Tiny biodegradable rod-like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three-dimensional scaffold, like pouring a box of matchsticks into a pile on a table…

Toughest breast cancer may have met its match: Protein inhibitor makes cell susceptible to chemotherapy

A report of their findings was published online in the journal Proceedings of the National Academy of Sciences on Dec. 1. Triple-negative breast cancers account for about 20 percent of all breast cancers in the United States, and 30 percent of all breast cancers in African-American women…

Targeting microRNA may benefit some ovarian and breast cancer patients

Researchers behind a study at The University of Texas MD Anderson Cancer Center believe they may have found a molecule-based approach to halting 3q26.2’s destructive nature. By manipulating a non-coding microRNA (miRNA) known as miR569 that is part of the amplicon, scientists were able to increase cell death in vitro and in vivo…

Young Puerto Rican women and their mothers know little about HPV, cervical cancer

According to the study published in Preventing Chronic Disease, a publication of the Centers for Disease Control and Prevention, HPV vaccination rates are low among Puerto Rican women. Fifty one percent of Puerto Rican girls aged 11 to 18 have started the 3-step vaccination process and only 21 percent have completed the series. “Our study is the first to provide insight into common psychosocial barriers affecting HPV vaccination in Puerto Rico,” said Mar�a E…

Older breast cancer patients still get radiation despite limited benefit

The study suggests that doctors and patients may find it difficult to withhold treatment previously considered standard of care, even in the setting of high quality data demonstrating that the advantages are small. “The onus is on physicians to critically analyze data to shape our treatment recommendations for patients, weighing the potential toxicities of treatment against clinical benefit,” said Rachel Blitzblau, M.D., Ph.D., the Butler Harris Assistant Professor of Radiation Oncology at Duke University Medical Center. Blitzblau was the senior author of a study published online Dec. 8, 2014, in the journal Cancer. …